Hepatosplenic T-cell lymphoma with hemophagocytic lymphohistiocytosis, revealed by fever of unknown origin

被引:0
作者
Kaoutar Meliani
Noufissa Alami Dribi
Widad Rhandour
Afaf Amarti Riffi
Zineb Khammar
Rhyzlane Berrady
机构
[1] CHU Hassan II,Department of Internal Medicine and Oncohematology
[2] CHU Hasssan II,Department of Anatomy and Pathology
来源
memo - Magazine of European Medical Oncology | 2023年 / 16卷
关键词
Cytogenetic karyotype; Fluorescence in situ hybridization; Molecular biology; Hepatosplenic T lymphoma gamma delta; Differential diagnosis;
D O I
暂无
中图分类号
学科分类号
摘要
The unusual peripheral lymphoma known as hepatosplenic T‑cell lymphoma (HSTCL) is a rare hematologic cancer. In this report, we discuss a case of HSTCL with hemophagocytic lymphohistiocytosis that was discovered due to a prolonged fever in a 27-year-old woman with no prior medical history. Infectious and autoimmune diseases were ruled out during the etiological review. Histopathological analysis of the bone marrow revealed hemophagocytosis. A diagnostic splenectomy was performed after the patient’s clinical condition worsened, showing no response to corticosteroids, and notable splenomegaly and hepatomegaly were observed on the positron emission tomography (PET) scan. The diagnosis of HSTCL was confirmed through pathological examination of the surgical specimens. In addition, a complementary genetic analysis revealed a gamma-delta T‑cell lymphoma. Hemophagocytic lymphohistiocytosis remains a diagnostic and therapeutic challenge, and physicians should always consider the possibility of an underlying hematologic disorder. Our case highlights the difficulties in diagnosing HSTCL due to the various possible causes of prolonged fever of unknown origin, as well as the nonspecific clinical presentation and the absence of peripheral lymphadenopathy. Our report discusses a new case of HSTCL associated with hemophagocytic lymphohistiocytosis to raise awareness among physicians about this rare entity. This association can be confusing and may lead to delays in diagnosis and thus worsening prognosis.
引用
收藏
页码:208 / 212
页数:4
相关论文
共 50 条
[1]  
Pro B(2020)Hepatosplenic T-cell lymphoma: a rare but challenging entity Blood 136 2018-2026
[2]  
Allen P(2020)Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas Am J Hematol 95 151-155
[3]  
Behdad A(1999)Hepato-splenic gammadelta T-cell lymphoma: a rare entity mimicking the hemophagocytic syndrome Am J Hematol 60 61-65
[4]  
Foss FM(2010)Hepatosplenic T-cell lymphoma and inflammatory bowel disease J Crohns Colitis 4 511-522
[5]  
Horwitz SM(2017)Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review Ann Diagn Pathol 26 16-22
[6]  
Civallero M(2018)18F-FDG PET/CT findings in hepatosplenic Gamma-Delta T-cell lymphoma: case reports and review of the literature Am J Nucl Med Mol Imaging 8 137-142
[7]  
Nosari A(2017)Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK/T cell lymphomas: an international collaborative effort on behalf of the guidelines committee of the American society for blood and marrow transplantation Biol Blood Marrow Transplant 23 1826-1838
[8]  
Oreste PL(2014)Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis Mayo Clin Proc 89 484-492
[9]  
Biondi A(2020)Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019 Zhonghua Shao Shang Za Zhi 36 471-475
[10]  
Thai A(2015)Hemophagocytic lymphohistiocytosis Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis 2015 177-182